Literature DB >> 8905761

Contrast-enhancing progressive multifocal leukoencephalopathy: radiological and pathological correlations: case report.

H H Woo1, A R Rezai, E A Knopp, H L Weiner, D C Miller, P J Kelly.   

Abstract

OBJECTIVE AND IMPORTANCE: Progressive multifocal leukoencephalopathy (PML), a demyelinating disease caused by the JC papovavirus, is an opportunistic infection afflicting patients with impaired cellular immunity. Although initially described in patients with hematological malignancies, PML has become associated with several other immunocompromised states, particularly human immunodeficiency virus (HIV) infection. There are numerous central nervous system manifestations in patients with acquired immunodeficiency syndrome. A major characteristic that distinguishes PML from other more common lesions, such as toxoplasmosis or non-Hodgkin's lymphoma, is the lack of contrast enhancement. We describe a case of PML that exhibits contrast enhancement, and we conclude that the diagnosis of PML must be considered in patients with HIV who have contrast-enhancing lesions. CLINICAL
PRESENTATION: A 40-year-old woman presented with progressive hemiparesis, blurred vision, and ataxia. Magnetic resonance imaging revealed a contrast-enhancing lesion involving the left middle cerebellar peduncle, causing mild compression of the fourth ventricle. INTERVENTION: The patient underwent a stereotactic serial biopsy with the presumptive diagnosis of moderate- to high-grade glioma. Histological examination of the biopsy specimen revealed early PML. Subsequently, a test for HIV was obtained and the results were positive.
CONCLUSION: We have reported another atypical radiographic characteristic of PML associated with HIV. We conclude that PML lesions can enhance after the administration of gadolinium. Therefore, the diagnosis of PML must be entertained in patients whose test results were positive for HIV with contrast-enhancing lesions and that a stereotactic serial biopsy may be necessary to provide a definitive diagnosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8905761     DOI: 10.1097/00006123-199611000-00029

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  4 in total

Review 1.  The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: study of 43 cases with review of the literature.

Authors:  Paola Cinque; Simona Bossolasco; Anna Maria Brambilla; Antonio Boschini; Cristina Mussini; Chiara Pierotti; Adriana Campi; Salvatore Casari; Davide Bertelli; Maurizio Mena; Adriano Lazzarin
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

2.  Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy.

Authors:  M M Thurnher; M J Post; A Rieger; C Kleibl-Popov; C Loewe; E Schindler
Journal:  AJNR Am J Neuroradiol       Date:  2001-05       Impact factor: 3.825

3.  Inflammatory infratentorial progressive multifocal leukoencephalopathy in a patient with rheumatoid arthritis.

Authors:  Boleslaw Lach; Barbara Connolly; Christian Wüthrich; Igor J Koralnik
Journal:  Neuropathology       Date:  2013-05-20       Impact factor: 1.906

Review 4.  Opportunistic infections of the CNS in patients with AIDS: diagnosis and management.

Authors:  Julio Collazos
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.